Pfizer Inc. (PFE)
NYSE: PFE · IEX Real-Time Price · USD
+0.43 (1.59%)
At close: Jun 18, 2024, 4:01 PM
-0.03 (-0.11%)
After-hours: Jun 18, 2024, 4:38 PM EDT

Pfizer Revenue

Pfizer had revenue of $55.09B in the twelve months ending March 31, 2024, down -40.86% year-over-year. Revenue in the quarter ending March 31, 2024 was $14.88B, a -19.51% decrease year-over-year. In the year 2023, Pfizer had annual revenue of $58.50B, a decrease of -41.70%.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
155.32B USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 202358.50B-41.83B-41.70%
Dec 31, 2022100.33B19.04B23.43%
Dec 31, 202181.29B39.64B95.16%
Dec 31, 202041.65B746.00M1.82%
Dec 31, 201940.91B80.00M0.20%
Dec 31, 201840.83B-11.72B-22.31%
Dec 31, 201752.55B-278.00M-0.53%
Dec 31, 201652.82B3.97B8.13%
Dec 31, 201548.85B-754.00M-1.52%
Dec 31, 201449.61B-1.98B-3.84%
Dec 31, 201351.58B-3.07B-5.62%
Dec 31, 201254.66B-6.38B-10.45%
Dec 31, 201161.04B-4.13B-6.34%
Dec 31, 201065.17B15.90B32.26%
Dec 31, 200949.27B973.00M2.01%
Dec 31, 200848.30B-122.00M-0.25%
Dec 31, 200748.42B47.00M0.10%
Dec 31, 200648.37B966.00M2.04%
Dec 31, 200547.41B-1.58B-3.23%
Dec 31, 200448.99B4.25B9.50%
Dec 31, 200344.74B12.44B38.53%
Dec 31, 200232.29B3.27B11.27%
Dec 31, 200129.02B2.98B11.44%
Dec 31, 200026.05B-1.12B-4.13%
Dec 31, 199927.17B3.94B16.94%
Dec 31, 199823.23B12.18B110.14%
Dec 31, 199711.06B1.19B12.07%
Dec 31, 19969.86B-157.00M-1.57%
Dec 31, 199510.02B2.04B25.62%
Dec 31, 19947.98B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Elevance Health 171.75B
Sanofi 51.60B
Novartis AG 49.92B
Thermo Fisher 42.49B
Abbott Laboratories 40.33B
Amgen 29.53B
Danaher 22.52B
Stryker 20.96B
Revenue Rankings